CV Sciences Investor Relations Material
Latest events
Q4 2024
CV Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CV Sciences Inc
Access all reports
CV Sciences Inc. is a life sciences company focused on developing and commercializing products derived from hemp-based cannabidiol (CBD). The company's offerings include consumer health products, such as dietary supplements and topical formulations, that promote wellness and support various health needs. CV Sciences operates through two primary segments: consumer products and drug development. The consumer products division produces CBD-based products under the PlusCBD brand, while the drug development segment is involved in researching CBD-based therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the OTCQB.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CVSI
Country
🇺🇸 United States